Establishment of antigen MAGE-3 gene vaccine and primary study of its immune activity

FANG Yao-Min,CHEN Yu-Bing

DOI: https://doi.org/10.3969/j.issn.1000-484X.2013.12.021

2013-01-01

Abstract:Objective: To construct tumor antigen MAGE 3 gene vaccine,and to observe its ability to induce an immune re- sponse. Methods: The plasmid pEGFP-MAGE3 was constructed with MAGE-3 objective gene and FGFP reporter gene. Then the pEG- FP-MAGE3 was transfected to LA795cells with transfection reagent after enzyme digestion. The pEGFP-MAGE3 plasmid transfected positive LA795 cell clone was selected with G418. The expression of EGFP was observed under the fluorescence microscope and MAGE- 3 mRNA were detected by RT-PCR. The C57BL /6J mice were immunized with pEGFP-MAGE3 vaccines three times with the interal of 10 days. After the last vaccines splenic CTL killing rate of immune mice was detected with LDH release assay and the cytokine IL-2 and IFN-gamma concentrations in supernatant of spleen cells was detected with ELISA method. Results: The pEGFP-MAGE3 plasmid was successfully constructed. Green fluorescen were seen in cells transfected pEGFP-MAGE3 plasmid for 24 hours. There were MAGE-3 and EGFP DNA bands at 1 000 and 750 bp position respectively by RT-PCR in the transfected cells. Experiment results showed splenic CTL killing rate of immune mice to B16 was significantly higher than that in control groups( P < 0. 05) The cytokine IL-2 and IFN-gam- ma concentrations in supernatant of spleen cells also increased significantly. Conclusion: The antigen MAGE 3 gene vaccine is suc- cessfully established. The vaccine can effectively induce specific immune response,which will provide experimental basis on immuno- therapy for cancer using MAGE-3 as target antigen.